Fig. 5From: The relationship between the use of GLP-1 receptor agonists and the incidence of respiratory illness: a meta-analysis of randomized controlled trialsSubgroup analysis: GLP-1 receptor agonists and Respiratory disease. CVOT: Cardiovascular Outcomes TrialBack to article page